Krogulski Kenneth's Form 4 filing
Cumberland Pharmaceuticals Inc (CPIX) · filed Dec 23, 2022
- Accession no.
- 0001209191-22-062649
- Filed
- Dec 23, 2022
- Trade date
- Dec 1-21, 2022
- Filing delay
- 22 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 15 non-derivative transactions and 0 derivative transactions. Open-market purchases total $6.78K. It was filed 22 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Krogulski KennethCIK 0001695580 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | Common Stock | PPurchaseAcquired | +105 | $2.33 | +$244.65 | 202,010 | Direct | |
| Dec 2, 2022 | Common Stock | PPurchaseAcquired | +105 | $2.31 | +$242.55 | 202,115 | Direct | |
| Dec 5, 2022 | Common Stock | PPurchaseAcquired | +105 | $2.19 | +$229.95 | 202,220 | Direct | |
| Dec 6, 2022 | Common Stock | PPurchaseAcquired | +105 | $2.19 | +$229.95 | 202,325 | Direct | |
| Dec 7, 2022 | Common Stock | PPurchaseAcquired | +105 | $2.18 | +$228.9 | 202,430 | Direct | |
| Dec 8, 2022 | Common Stock | PPurchaseAcquired | +105 | $2.19 | +$229.95 | 202,535 | Direct | |
| Dec 9, 2022 | Common Stock | PPurchaseAcquired | +105 | $2.15 | +$225.75 | 202,640 | Direct | |
| Dec 12, 2022 | Common Stock | PPurchaseAcquired | +105 | $2.14 | +$224.7 | 202,745 | Direct | |
| Dec 13, 2022 | Common Stock | PPurchaseAcquired | +320 | $2.18 | +$697.6 | 203,065 | Direct | |
| Dec 14, 2022 | Common Stock | PPurchaseAcquired | +320 | $2.21 | +$707.2 | 203,385 | Direct | |
| Dec 15, 2022 | Common Stock | PPurchaseAcquired | +144 | $2.24 | +$322.56 | 203,529 | Direct | |
| Dec 16, 2022 | Common Stock | PPurchaseAcquired | +246 | $2.22 | +$546.12 | 203,775 | Direct | |
| Dec 19, 2022 | Common Stock | PPurchaseAcquired | +450 | $2.21 | +$994.5 | 204,225 | Direct | |
| Dec 20, 2022 | Common Stock | PPurchaseAcquired | +370 | $2.31 | +$854.7 | 204,595 | Direct | |
| Dec 21, 2022 | Common Stock | PPurchaseAcquired | +360 | $2.22 | +$799.2 | 204,955 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.